Formula Growth’s NEVRO CORP. NVRO Stock Holding History

Formula Growth’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,500	Closed	-$783K	–	150
2016 Q3	$783K	Buy	+7,500	New	+$677K	0.18%	141

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Formula Growth's NVRO Position: Q4 2016 in Review

Formula Growth sold out of NEVRO CORP. (NVRO) in Q4 2016, closing a stake of 7,500 shares — an estimated $783K sold.

Formula Growth first reported a position in NVRO in Q3 2016 and held it in 1 quarter. The position peaked at $783K in Q3 2016. 174 funds tracked by Wall St. Rank hold NVRO as of Q4 2016.

Formula Growth reported no remaining NEVRO CORP. position as of Q4 2016 after selling out during the quarter.
Formula Growth sold 7,500 NEVRO CORP. shares in Q4 2016, an estimated $783K.
Formula Growth first reported a position in NEVRO CORP. in Q3 2016 and held it in 1 quarter.
Formula Growth's NEVRO CORP. position peaked at $783K in Q3 2016.
174 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2016.

Based on Formula Growth's 13F filing for Q4 2016, filed 13 Feb 2017.